NLRP1 and Alzheimer disease: Recently, Saresella and colleagues found that inflammasome components (NLRP1, NLRP3, PYCARD, CASP1, CASP5, and CASP8) and downstream effectors (IL1B, IL18) were upregulated in peripheral blood mononuclear cells from patients with moderate and severe AD [70].